ArticleInfection and immunity2026
Lipidated Protein D vaccination elicits humoral and cellular responses and protects mice against challenge with non-typeable
Terri C Thayer, Andrew Cox, Eduardo Gonzalez, Jill Mangiafesto, Lei Xu, Michael Pichichero, Ravinder Kaur
Abstract read
In one paragraphArticle in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Terri C ThayerCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.ORCID 0000-0003-1954-6305 Andrew CoxCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.ORCID 0000-0003-3485-8892 Eduardo GonzalezCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
Jill MangiafestoCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
Lei XuCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
Michael PichicheroCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.ORCID 0000-0002-8276-3938 Ravinder KaurCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.ORCID 0000-0001-6539-5339 Funding
Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform developmentR01AI187168 · NIAID · ROCHESTER GENERAL HOSPITAL (NY) · PI Ravinder Kaur, MICHAEL E PICHICHERO · 2025 to 2026
$807kNIAID NIH HHS R01 AI187168NIH HHS 1R01AI187168-01
6 · The paper itselfAbstract
Indexed as
Bacterial Outer Membrane ProteinsCarrier StateHaemophilus InfectionsHaemophilus influenzaeHaemophilus VaccinesAdjuvants, ImmunologicAlum CompoundsAnimalsAntibodies, BacterialCell LineDisease Models, AnimalFemaleHumansImmunity, CellularImmunity, HumoralImmunoglobulin GAdjuvants, ImmunologicAlum Compoundsaluminum sulfateAntibodies, BacterialBacterial Outer Membrane ProteinsHaemophilus VaccinesImmunoglobulin Gacute otitis mediaaluminum hydroxideantibodyear infection modelHaemophilus influenzaelipoproteinnasopharyngeal colonizationProtein DTh17 cellsvaccination
Identifiers
PMID41914730
PMCPMC13163197
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390